Clinical Trial Update: Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder [NA]

View source ↗

Summary

This completed Phase II trial evaluated concurrent intravesical Bacillus Calmette-Guérin (BCG) and interferon for treatment and prevention of recurrence of supe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transitional Cell Carcinoma of the Bladder

Drugs mentioned

• Bacillus Calmette-Guérin (Bacillus Calmette-Guérin)
• Interferon Alfa (interferon alfa)

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Transitional Carcinoma of Urinary Bladder | NA | Status: COMPLETED